Drug profile · INN
trientine tetrahydrochloride
CUVRIOR
trientine tetrahydrochloride (CUVRIOR) is a copper chelating agent. Route of administration: oral. Current US regulatory status: approved.
Drug details — trientine tetrahydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
trientine tetrahydrochloride (CUVRIOR) is a copper chelating agent. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Copper chelating agent
Primary target: Copper
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is trientine tetrahydrochloride?
trientine tetrahydrochloride (CUVRIOR) is a copper chelating agent. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trientine tetrahydrochloride?
CUVRIOR is a marketed brand name for trientine tetrahydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trientine tetrahydrochloride?
trientine tetrahydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.